Patent Assignment
Reel/Frame 051441/0409
Assignment of Assignor's Interest
Recorded: 2020-01-07
Pages: 12
Assignor
UCB PHARMA S.A.
Executed: 2018-02-21
Assignee
UCB BIOPHARMA SPRL
ALLEE DE LA RECHERCHE, 60, BRUSSELS, 1070, BELGIUM
Covered Property
(1)
Fused Pentacyclic Imidazole Derivatives as Modulators of TNF Activity
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 7, 2020
From: BROOKINGS, DANIEL CHRISTOPHER; BROWN, JULIAN ALISTAIR; HEER, JAG PAUL; JOHNSON, JAMES ANDREW
To: CELLTECH R&D LIMITED
Reel/Frame 051441/0281 →
Assignment of Assignor's Interest
Jan 7, 2020
From: CELLTECH R&D LIMITED
To: UCB S.A.
Reel/Frame 051441/0376 →
Assignment of Assignor's Interest
Jan 7, 2020
From: UCB S.A.
To: UCB PHARMA S.A.
Reel/Frame 051441/0397 →
Assignment of Assignor's Interest
Jan 8, 2020
From: UCB BIOPHARMA SPRL
To: SANOFI; UCB BIOPHARMA SPRL
Reel/Frame 051445/0936 →
Change of Name
Jan 12, 2021
From: UCB BIOPHARMA SPRL (SOCIETE PRIVEE A RESPONSABILITE LIMITEE)
To: UCB BIOPHARMA SRL (SOCIETE A RESPONSABILITE LIMITEE)
Reel/Frame 054971/0876 →